Prostatakarzinom

Translated title of the contribution: Prostate carcinoma

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Prostate cancer is the most common malignancy in men in Europe, North America, and in some African states. Early diagnosis in an asymptomatic stage is possible through the combination of digitorectal examination, PSA serum testing, and systematic biopsy. However, general screening is so far not recommended by the Urologic Societies, because the efficiency is not yet proved. Imaging is also not recommended for first-line screening. Novel functional methods of transrectal ultrasound (TRUS) and endorectal MRI can improve accuracy of tumor detection to more than 90% and can be used for TRUS- and now also MRI-guided biopsy leading to two- to threefold higher tumor detection rates. There is general agreement that all men over 50 years of age should be informed about the possibilities, benefits, and risks of the available methods for early tumor detection.

Original languageGerman
Pages (from-to)45-51
Number of pages7
JournalRadiologe
Volume48
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Prostate
Carcinoma
Neoplasms
Biopsy
North America
Early Diagnosis
Prostatic Neoplasms
Serum

Keywords

  • Early detection
  • Epidemiology
  • Imaging
  • Prostate carcinoma
  • Screening

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Prostatakarzinom. / Schlemmer, Heinz-Peter.

In: Radiologe, Vol. 48, No. 1, 01.01.2008, p. 45-51.

Research output: Contribution to journalReview article

Schlemmer, Heinz-Peter. / Prostatakarzinom. In: Radiologe. 2008 ; Vol. 48, No. 1. pp. 45-51.
@article{73367f0c6dca43f08a2b9ad20eff1dc6,
title = "Prostatakarzinom",
abstract = "Prostate cancer is the most common malignancy in men in Europe, North America, and in some African states. Early diagnosis in an asymptomatic stage is possible through the combination of digitorectal examination, PSA serum testing, and systematic biopsy. However, general screening is so far not recommended by the Urologic Societies, because the efficiency is not yet proved. Imaging is also not recommended for first-line screening. Novel functional methods of transrectal ultrasound (TRUS) and endorectal MRI can improve accuracy of tumor detection to more than 90{\%} and can be used for TRUS- and now also MRI-guided biopsy leading to two- to threefold higher tumor detection rates. There is general agreement that all men over 50 years of age should be informed about the possibilities, benefits, and risks of the available methods for early tumor detection.",
keywords = "Early detection, Epidemiology, Imaging, Prostate carcinoma, Screening",
author = "Heinz-Peter Schlemmer",
year = "2008",
month = "1",
day = "1",
doi = "10.1007/s00117-007-1555-z",
language = "German",
volume = "48",
pages = "45--51",
journal = "Radiologe",
issn = "0033-832X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Prostatakarzinom

AU - Schlemmer, Heinz-Peter

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Prostate cancer is the most common malignancy in men in Europe, North America, and in some African states. Early diagnosis in an asymptomatic stage is possible through the combination of digitorectal examination, PSA serum testing, and systematic biopsy. However, general screening is so far not recommended by the Urologic Societies, because the efficiency is not yet proved. Imaging is also not recommended for first-line screening. Novel functional methods of transrectal ultrasound (TRUS) and endorectal MRI can improve accuracy of tumor detection to more than 90% and can be used for TRUS- and now also MRI-guided biopsy leading to two- to threefold higher tumor detection rates. There is general agreement that all men over 50 years of age should be informed about the possibilities, benefits, and risks of the available methods for early tumor detection.

AB - Prostate cancer is the most common malignancy in men in Europe, North America, and in some African states. Early diagnosis in an asymptomatic stage is possible through the combination of digitorectal examination, PSA serum testing, and systematic biopsy. However, general screening is so far not recommended by the Urologic Societies, because the efficiency is not yet proved. Imaging is also not recommended for first-line screening. Novel functional methods of transrectal ultrasound (TRUS) and endorectal MRI can improve accuracy of tumor detection to more than 90% and can be used for TRUS- and now also MRI-guided biopsy leading to two- to threefold higher tumor detection rates. There is general agreement that all men over 50 years of age should be informed about the possibilities, benefits, and risks of the available methods for early tumor detection.

KW - Early detection

KW - Epidemiology

KW - Imaging

KW - Prostate carcinoma

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=38649096647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649096647&partnerID=8YFLogxK

U2 - 10.1007/s00117-007-1555-z

DO - 10.1007/s00117-007-1555-z

M3 - Review article

C2 - 17909738

AN - SCOPUS:38649096647

VL - 48

SP - 45

EP - 51

JO - Radiologe

JF - Radiologe

SN - 0033-832X

IS - 1

ER -